Lv61
1604 积分 2023-05-24 加入
RIPTACs: A groundbreaking approach to drug discovery
13天前
已完结
LZTR1Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
1个月前
已完结
AXL/MET Dual Inhibitor, CB469, Has Activity in Non-Small Cell Lung Cancer With Acquired Resistance to EGFR TKI With AXL or MET Activation
1个月前
已关闭
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR -mutant lung cancer
1个月前
已完结
Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC
1个月前
已完结
Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer
1个月前
已完结
Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal–Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer
1个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
1个月前
已完结
Circulating small extracellular vesicles promote proliferation and migration of vascular smooth muscle cells via AXL and MerTK activation
2个月前
已完结
Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-γ signalling
2个月前
已完结
皖公网安备34019202002308
